| |
| |
|
| Insider
Information: |
Rowinsky Eric K |
| Relationship: |
Director |
| City: |
Branchburg |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
589,560 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$6,308,989 |
|
|
|
Indirect Value
|
$7,980 |
|
|
| Total
Shares |
591,560 |
|
|
| Total
Value |
$6,316,969 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
-5.0
|
| Percentage
Gain/Loss : |
 -32.4%
|
-94.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Director |
2024-02-15 |
20,629 |
2010-03-22 |
0 |
Premium* |
|
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2018-02-20 |
341,446 |
2011-08-19 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Chief Medical Officer |
2015-04-27 |
143,688 |
2013-04-24 |
0 |
Premium* |
|
|
Fortress Biotech, Inc. |
FBIO |
Director |
2024-01-01 |
68,797 |
2014-02-20 |
0 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-29 |
15,000 |
2016-08-29 |
0 |
Premium* |
|
|
Verastem, Inc. |
VSTM |
Director |
2017-09-05 |
0 |
2017-09-05 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-03-17 |
4 |
OE |
$59.82 |
$279,180 |
D/D |
4,667 |
15,977 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2010-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,735 |
6,235 |
0 |
- |
|
| FBIO |
Fortress Biotech, Inc. |
Director |
– • – |
2021-02-18 |
4 |
S |
$4.20 |
$25,200 |
D/D |
(6,000) |
738,000 |
0 |
% |
|
| FBIO |
Fortress Biotech, Inc. |
Director |
– • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,666 |
68,797 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
• – – |
2013-08-01 |
4 |
D |
$27.88 |
$188,051 |
D/D |
(6,745) |
143,869 |
0 |
- |
|
| FBIO |
Fortress Biotech, Inc. |
Director |
– • – |
2021-02-19 |
4 |
S |
$4.31 |
$34,480 |
D/D |
(8,000) |
730,000 |
0 |
% |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2014-11-10 |
4 |
A |
$1.32 |
$12,500 |
D/D |
9,470 |
163,720 |
0 |
- |
|
| FBIO |
Fortress Biotech, Inc. |
Director |
– • – |
2021-03-02 |
4 |
S |
$4.45 |
$44,500 |
D/D |
(10,000) |
720,000 |
0 |
% |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2016-04-08 |
4 |
A |
$1.14 |
$12,228 |
D/D |
10,726 |
196,446 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-04-27 |
4 |
S |
$15.77 |
$170,694 |
D/D |
(10,824) |
143,688 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
• – – |
2014-04-25 |
4 |
S |
$15.01 |
$168,004 |
D/D |
(11,179) |
131,773 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-03-20 |
4 |
AS |
$475.00 |
$5,541,825 |
D/D |
(11,667) |
11,310 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-03-20 |
4 |
OE |
$59.82 |
$697,920 |
D/D |
11,667 |
22,977 |
0 |
- |
|
| FBIO |
Fortress Biotech, Inc. |
Director |
– • – |
2023-02-10 |
4 |
B |
$0.84 |
$10,000 |
D/D |
11,976 |
931,976 |
2.39 |
% |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
104,250 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-01-06 |
4 |
OE |
$59.82 |
$777,181 |
D/D |
12,992 |
20,802 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2012-01-06 |
4 |
AS |
$116.00 |
$1,507,072 |
D/D |
(12,992) |
9,135 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
• – – |
2013-11-25 |
4 |
S |
$20.56 |
$285,846 |
D/D |
(13,903) |
128,966 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
• – – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,986 |
142,952 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2011-08-19 |
4 |
B |
$2.55 |
$38,250 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| BIND |
DNIB Upwind Inc |
Director |
– • – |
2016-08-29 |
4 |
OE |
$0.44 |
$6,600 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
62,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2014-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
154,250 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2015-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
185,720 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,379 |
154,512 |
0 |
- |
|
68 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
